<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> is concomitant with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, and other features of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Because <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> is associated with <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, both scientists and physicians have taken great interest in this disorder </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> is associated with compensatory <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, but individual contributions of either of these two conditions remain incompletely understood and a subject of intense investigation </plain></SENT>
<SENT sid="3" pm="."><plain>One possibility is that in an attempt to overcome the inhibition within the metabolic insulin-signaling pathway, <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> may continue to stimulate the mitogenic insulin-signaling pathway, thus exerting its detrimental influence </plain></SENT>
<SENT sid="4" pm="."><plain>Here we discuss some of the effects of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and mechanisms of potentially detrimental influence of <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> in the presence of metabolic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
</text></document>